Latest / AI for Founders with Ryan Estes
15 beagles, 4 cancers, 94% accuracy: my favorite AI workflow in health tech
Thirteen days from now, the FDA convenes a panel that has never convened before.
On September 23, 2026, the Molecular and Clinical Genetics Panel sits down to vote on Grail's Galleri test, the first multi-cancer early detection test ever to reach an FDA advisory committee. Every founder building in early detection is watching. Shlomi Madar is watching too. He just is not building the same thing.
Madar is the CEO of SpotitEarly, an Englewood, New Jersey company founded in 2020 that screens for four cancers from a single breath sample collected at your kitchen table. Grail reads methylation…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.